Gastroparez:etiologiya, patogenez, diagnostika i terapiya


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The article reflects the current state of the question about the diagnosis and treatment of such common, but rarely diagnosed functional disorders of gastric motility as gastroparesis. The main etiopathogenic types of the disease and algorithm for the management of patients with clinical signs of this disease are discussed.

Толық мәтін

Рұқсат жабық

Авторлар туралы

I. Maev

A. Samsonov

D. Bordin

D. Andreev

Email: dna-mit8@mail.ru

Әдебиет тізімі

  1. Camilleri M. Clinical practice. Diabetic gastroparesis. N. Engl. J. Med. 2007;356:820-29.
  2. Karamanolis G., Caenepeel P., Arts J., et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut. 2007;56:29-36.
  3. Camilleri M., Bharucha A.E., Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin. Gastroenterol. Hepatol. 2011;9:5-12.
  4. Sarnelli G., Caenepeel P., Geypens B., et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am. J. Gastroenterol. 2003;98:783-88.
  5. Tack J., Bisschops R., Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127:1239-55.
  6. Samsom M., Vermeijden J.R., Smout A.J., et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care. 2003;26:3116.
  7. Revicki D.A., Rentz A.M., Dubois D., et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual. Life Res. 2004;13:833.
  8. Revicki D.A., Rentz A.M., Tack J., et al. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin. Gastroenterol. Hepatol. 2004;2:769.
  9. Abell T.L., Runnels M., Thompson R.W., et al. A double-blind, randomized, placebo-controlled study of temporary endoscopic mucosal gastric electrical stimulation in gastropare-sis: the EndoStim study. Gastrointest. Endosc. 2011;74(3):496-503.
  10. Parkman H.P., Camilleri M., Ffrrugia G., et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol. Motil. 2010; 22(2):113-33.
  11. Stanghellini V., Tosetti C., Paternico A., et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;10:1036-42.
  12. Jung H.K., Choung R.S., Locke G.R., et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota from 1996 to 2006. Gastroenterology. 2009;136:1225-33.
  13. Maleki D., Locke G.R., Camilleri M., et al. Gastrointestinal symptoms among persons with diabetes in the community. Archives Intern. Med. 2000;160:2808-16.
  14. Bharucha A.E., Camilleri M., Forstrom L., et al. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin. Endocrinol. 2009;70:415-20.
  15. Choung R.S., Locke G.R., Schleck C.D., et al. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am. J. Gastroenterol. 2012;107:82-8.
  16. Hyett B., Martinez F.J., Gill B.M., et al. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology. 2009;137:445-52.
  17. Parkman H.P., Yates K., Hasler W.L., et al. Similarities and diff erences between diabetic and idiopathic gastroparesis. Clin. Gastroenterol. Hepatol. 2011;9:1056-64.
  18. Camilleri M., Parkman H.P., Shafi M.A., et al. Clinical Guideline: Management of Gastroparesis. Am. J. Gastroenterology. 2013;108:18-37.
  19. Abell T.L., Camilleri M., Donohoe K., et al. Consensus recommendations for gastric emptying scintigraphy. A Joint Report of the Society of Nuclear Medicine and the American Neurogastroenterology and Motility Society. Am. J. Gastroenterol. 2008;103:753-63.
  20. Ahmed A.B., Gilja O.H., Hausken T., et al. Strain measurement during antral contractions by ultrasound strain rate imaging: influence of erythromycin. Neurogastroenterol. Motil. 2009;21:170-79.
  21. Mundt M.W., Samsom M. Fundal dysaccommodation in functional dyspepsia: head-to-head comparison between the barostat and threedimensional ultrasonographic technique. Gut. 2006;55:1725-30.
  22. Soykan I., Sarosiek I., McCallum R.W. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am. J. Gastroenterol. 1997;92(6):976-80.
  23. Dooley C.P., El Newihi H.M., Zeidler A., et al. Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea. Scand. J. Gastroenterol. 1988;23:217.
  24. Camilleri M., Malagelada J.R., Brown M.L., et al. Relation between antral motility and gastric emptying of solids and liquids in humans. Am. J. Physiol. 1985;49:G580-85.
  25. Fich A., Neri M., Camilleri M., et al. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J. Clin. Gastroenterol. 1990;12:505-12.
  26. Camilleri M., Grover M., Farrugia G. What are the important subsets of gastroparesis? Neurogastroenterol. Motil. 2012;24:597-603.
  27. Vinik A.I., Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-97.
  28. Choi K.M., Gibbons S.J., Nguyen T.V., et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology. 2008;135:2055-64.
  29. Grover M., Bernard C.E., Pasricha P.J., et al. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical. Research. Consortium. Neurogastroenterol. Motil. 2012;24:531-40.
  30. Samsom M., Bharucha A., Gerich J., et al. Diabetes mellitus and gastric emptying: questions and issues in clinical practice. Diabetes Metab. Res. Rev. 2009;6:502-14.
  31. Frank J.W., Saslow S.B., Camilleri M., et al. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology. 1995;109:755.
  32. Fraser R.J., Horowitz M., Maddox A.F., et al. Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:675.
  33. Ueno N., Inui A., Asakawa A., et al. Erythromycin improves glycaemic control in patients with type II diabetes mellitus. Diabetologia. 2000;43:411.
  34. Eagon J.C., Miedema B.W., Kelly K.A. Postgastrectomy syndromes. Surg. Clin. North. Am. 1992;72:445.
  35. Geldof H., van der Schee E.J., van Blankenstein M., et al. Effects of highly selective vagotomy on gastric myoelectrical activity. Dig. Dis. Sci. 1990;35:969.
  36. Sarosiek I., Yates K.P., Abell T.L., et al. Interpreting symptoms suggesting gastroparesis in patients after gastric and esophageal surgeries. Gastroenterology. 2011;140:S813.
  37. Lundell L.R., Myers J.C., Jamieson G.G. Delayed gastric emptying and its relationship to symptoms of «gas bloat» after antireflux surgery. Eur. J. Surg. 1994;160:161-66.
  38. DeVault K.R., Floch N.R., Achem S.R., et al. Vagal nerve dysfunction before and after antireflux surgery. Am. J. Gastroenterol. 2001;96:S10.
  39. Parkman H.P., Yates K., Hasler W.L., et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin. Gastroenterol. Hepatol. 2011;9:1056-64.
  40. Soykan I., Sivri B., Sarosiek I., et al. Demography, clinical characteristics, psychological profiles, treatment and longterm follow-up of patients with gastroparesis. Dig. Dis. Sci. 1998;43:2398-404.
  41. Grover M., Farrugia G., Lurken M.S., et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140:1575-85.
  42. Rao A.S., Camilleri M. Review article: metoclopramide tardive dyskinesia. Aliment. Pharmacol. Ther. 2010;31:11-9.
  43. Savant P., Das H.S., Desai N., et al. Comparativ evaluation of the effiacacy and tolerability of itoprid hydrochloride and domperidone in patients with non-ulcer dyspepsia. JAPI. 2004; 52:626-28.
  44. Holtman G., Talley N.J., Libgrets T., et al. A placebo-controlled trial of itopride in functional dyspepsia. N. Engl. J. Med. 2006;354:832-40.
  45. Noritake M., Kikuchy Y., Otsubo T., et al. Effect of itopride hydrochloride on diabetic gastroparesis. Kiso To Rinsho. 1997;8:2785-91.
  46. Abell T., McCallum R., Hocking M., et al. Gastric electrical stimulation for medicallyre-fractory gastroparesis. Gastroenterology. 2003;125:421-28.
  47. Abell T.L., Van Cutsem E., Abrahamsson H., et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion. 2002;66:204-12.
  48. O'Grady G., Egbuji J.U., Du P., et al. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World. J.Surg. 2009;33:1693-701.
  49. Chu H., Lin Z., Zhong L., et al. A meta-analysis: the treatment of highfrequency gastric electrical stimulation for gastroparesis. J. Gastroenterol. Hepatol. 2012;27:1017-26.
  50. Chandrasekharan B., Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol. Motil. 2007;19:951-60.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2015

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>